Very poor long-term survival in past and more recent studies for relapsed AML patients: The ECOG-ACRIN experience.
Ganzel C, Sun Z, Cripe LD, Fernandez HF, Douer D, Rowe JM, Paietta EM, Ketterling R, O'Connell MJ, Wiernik PH, Bennett JM, Litzow MR, Luger SM, Lazarus HM, Tallman MS.
Ganzel C, et al.
Am J Hematol. 2018 Aug;93(8):1074-1081. doi: 10.1002/ajh.25162.
Am J Hematol. 2018.
PMID: 29905379
Free PMC article.